Gastroenterology & Microbiome
Globally, Ferring is taking on some of the most pervasive diseases of the digestive system that burden millions of people and their families. Our curiosity helps us tackle health issues differently.
Within our portfolio, we offer treatments for every stage of the patient’s journey with Crohn’s Disease, a debilitating chronic condition that causes inflammation of the digestive track1.
We are transforming the potential of microbiome restoration into novel live biotherapeutics. Harnessing that power requires the kind of inquisitive minds, innovative problem solving, rigorous scientific standards, and leadership that have been the foundation of Ferring for 70 years.
Ferring has embarked on a bold new course, pioneering a potential category of microbiome-based therapeutics to help people live better lives and advance current standards of care. While we are starting with recurrent C. difficile infection, we believe this is only the beginning of how we harness the power of the microbiome to fight disease.
- Crohn’s & Colitis Foundation. The Facts About Inflammatory Bowel Diseases. November 2014. Available at: https://www.crohnscolitisfoundation.org/sites/default/files/2019-02/Updated%20IBD%20Factbook.pdf. Last accessed: August 2020